| 摘要 |
<p>The invention concerns a pharmaceutical composition to be used for diagnosing and/or treating angiogenic sources by being administered to a subject by systemic administration, said composition containing mammalian cells optionally comprising an active substance for diagnosing and/or treating angiogenic sources. The invention is characterised in that said cells are immortalised.</p> |
